Friday, March 13, 2020 10:32:37 AM
"DHR) (the "Company" or "Discovery Harbour") announces that, due to the recent extraordinary downturn of global financial market conditions associated with the novel coronavirus outbreak, it is suspending the Company's non-brokered private placement (the "Offering") announced on February 3, 2020 for 30 days, during which time the Company will reassess market conditions to determine whether the Offering will continue. The Company closed the initial tranche of the Offering in the amount of $187,500 pursuant to a news release dated February 25, 2020. Management is hopeful that market conditions will stabilize over the coming weeks so that it can complete the balance of the Offering. However, Management can provide no assurance it can complete the balance of the Offering within the next 30 days given that the market downturn and events which may have caused it are beyond the Company's control.
Recent DHR News
- Danaher Schedules Third Quarter 2024 Earnings Conference Call • PR Newswire (US) • 09/19/2024 08:30:00 PM
- Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership • PR Newswire (US) • 09/17/2024 12:30:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 09/10/2024 08:15:00 PM
- Danaher Confirms Third Quarter and Full Year 2024 Guidance • PR Newswire (US) • 09/04/2024 08:30:00 PM
- Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. • PR Newswire (US) • 08/26/2024 09:30:00 PM
- Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration • PR Newswire (US) • 07/25/2024 01:00:00 PM
- Danaher Reports Second Quarter 2024 Results • PR Newswire (US) • 07/23/2024 10:00:00 AM
- Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development • PR Newswire (US) • 07/17/2024 11:30:00 AM
- Danaher Releases 2024 Sustainability Report • PR Newswire (US) • 07/16/2024 11:30:00 AM
- Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening • PR Newswire (US) • 07/11/2024 11:30:00 AM
- Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer • PR Newswire (US) • 07/09/2024 07:00:00 AM
- Danaher Schedules Second Quarter 2024 Earnings Conference Call • PR Newswire (US) • 06/24/2024 08:30:00 PM
- Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics • PR Newswire (US) • 06/19/2024 11:30:00 AM
- Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer • PR Newswire (US) • 06/05/2024 11:00:00 AM
- Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis • PR Newswire (US) • 05/09/2024 11:00:00 AM
- Danaher to Present at Bank of America Securities Healthcare Conference • PR Newswire (US) • 05/07/2024 08:45:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 05/07/2024 08:15:00 PM
- Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry • PR Newswire (US) • 05/03/2024 01:06:00 PM
- Danaher Reports First Quarter 2024 Results • PR Newswire (US) • 04/23/2024 10:00:00 AM
- Danaher Schedules First Quarter 2024 Earnings Conference Call • PR Newswire (US) • 03/21/2024 08:15:00 PM
- Danaher to Present at TD Cowen Health Care Conference • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets • PR Newswire (US) • 02/22/2024 09:15:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 02/21/2024 09:15:00 PM
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development • PR Newswire (US) • 02/05/2024 12:30:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM